Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 2/20 | 0.67 |
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | MMP3 | P08254 | 1/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
| ▸ | MMP12 | P39900 | 1/20 | 0.51 |
| ▸ | MMP13 | P45452 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 5/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | RECQL | P46063 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL21834067 | 0.98 | LCK (0.65) | LCKMMP1MMP2MMP3MMP9 | |
| SCHEMBL21834064 | 0.88 | LCK (0.53) | LCKMMP1MMP2MMP3MMP9 | |
| SCHEMBL14617725 | 0.88 | LCK (0.53) | LCKMMP1MMP2MMP3MMP9 | |
| SCHEMBL8008620 | 0.88 | LCK (0.67) | LCKMMP1MMP2MMP3MMP9 | |
| SCHEMBL25100766 | 0.87 | LCK (0.52) | LCKMMP1MMP2MMP3MMP9 | |
| SCHEMBL15149699 | 0.87 | CA2 (0.56) | LCKOPRK1HSD17B2CA1CA2 | |
| SCHEMBL11539388 | 0.86 | LCK (0.65) | LCKMMP1MMP2MMP3MMP9 | |
| SCHEMBL25100998 | 0.85 | LCK (0.51) | LCKMMP1MMP2MMP3MMP9 | |
| SCHEMBL15976477 | 0.85 | LCK (0.71) | LCKMMP1MMP2MMP3MMP9 | |
| SCHEMBL10792638 | 0.85 | LCK (0.71) | LCKMMP1MMP2MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564596-B2 | Agents and methods for modulating pathogen activity | GRIFFITH UNIVERSITY (AU) | 2026-03-03 | — | — | US | claimed |
| EP-3856196-B1 | PHENYLPROPIONIC ACID DERIVATIVES FOR MODULATING PATHOGEN ACTIVITY | UNIV GRIFFITH (AU) | 2023-11-15 | — | — | EP | claimed |
| US-20210338685-A1 | AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 2021-11-04 | — | — | US | claimed |
| EP-3856196-A1 | AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY | Griffith University (AU) | 2021-08-04 | — | — | EP | claimed |
| CN-113164494-A | Agents and methods for modulating pathogen activity | 格里菲斯大学 | 2021-07-23 | — | — | CN | claimed |
| WO-2020061649-A1 | AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY | GRIFFITH UNIVERSITY (AU) | 2020-04-02 | — | — | WO | claimed |
| CN-105732416-A | Method for synthesizing Carbidopa | 青岛市黄岛区中医医院 | 2016-07-06 | — | — | CN | claimed |
| WO-2007042848-A2 | PROCESS FOR THE PREPARATION OF CARBIDOPA | EGIS GYÓGYSZERGYÁR (HU) | 2007-04-19 | — | — | WO | claimed |
| US-12564596-B2 | Agents and methods for modulating pathogen activity | GRIFFITH UNIVERSITY (AU) | 2026-03-03 | — | — | US | disclosed |
| CN-118986994-A | Agents and methods for modulating pathogen activity | 格里菲斯大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-113164494-B | Agents and methods for modulating pathogen activity | 格里菲斯大学 | 2024-08-27 | — | — | CN | disclosed |
| EP-4295864-A2 | PHENYLPROPIONIC ACID DERIVATIVES FOR MODULATING PATHOGEN ACTIVITY | Research Institute at Nationwide Children's Hospital (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-3856196-B1 | PHENYLPROPIONIC ACID DERIVATIVES FOR MODULATING PATHOGEN ACTIVITY | UNIV GRIFFITH (AU) | 2023-11-15 | — | — | EP | disclosed |
| US-20210338685-A1 | AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 2021-11-04 | — | — | US | disclosed |
| EP-3856196-A1 | AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY | Griffith University (AU) | 2021-08-04 | — | — | EP | disclosed |
| CN-113164494-A | Agents and methods for modulating pathogen activity | 格里菲斯大学 | 2021-07-23 | — | — | CN | disclosed |
| WO-2020061649-A1 | AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY | GRIFFITH UNIVERSITY (AU) | 2020-04-02 | — | — | WO | disclosed |
| CN-105732416-A | Method for synthesizing Carbidopa | 青岛市黄岛区中医医院 | 2016-07-06 | — | — | CN | disclosed |
| WO-2007042848-A2 | PROCESS FOR THE PREPARATION OF CARBIDOPA | EGIS GYÓGYSZERGYÁR (HU) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564596-B2 | Agents and methods for modulating pathogen activity | C3AR1, HTR3A, CHRM3 | LCK 2821/4885MMP1 3755/4885MMP2 2899/4885 |
| US-20210338685-A1 | AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY | C3AR1, HAVCR2, C5AR1 | LCK 612/4885MMP1 1161/4885MMP2 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.